CV5 Capital and Enzyme form a strategic partnership to launch institutional-grade tokenized fund solutions
Foresight News reported that CV5 Capital has announced a strategic partnership with global tokenized financial infrastructure provider Enzyme, which will serve as the foundational technology stack for its tokenized fund issuance and management. CV5 Capital plans to leverage Enzyme Onyx to build, launch, and manage a new generation of investment products, supporting investment strategies across a variety of asset classes including cryptocurrencies, securities, commodities, and US Treasuries.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The Dow Jones Index closed down 557.24 points, with both the S&P 500 and Nasdaq also declining.
The US Dollar Index rose by 0.29% on the 17th.
